Lactoferrin supplementation enhances natural killer cell activity in adults: findings from a 12-week randomized, double-blind, placebo-controlled trial
Journal of Functional Foods · 2026-11 · 146 · 107537
DOI: 10.1016/j.jff.2026.107537 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Functional Foods, 2026-11. Verfasst von Jong-Hwan Park und 5 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lactoferrin (LF), a component of the innate immune system found in human mucus, is known for its antimicrobial properties. It plays a crucial role in shaping immune function in newborns. Despite its biological significance and therapeutic potential, the clinical efficacy of LF in humans remains unclear. We conducted a 12-week, randomized, double-blind, placebo-controlled trial to evaluate the effects and safety of LF supplementation in adults. A total of 100 participants aged 20 years or older were randomly assigned in a 1:1 ratio to receive either LF (300 mg/day) or placebo. The primary endpoint was defined as the change in natural killer (NK) cell activity. Between-group differences in changes in NK cell activity varied according to the assessment time point and E:T ratio. At week 6, a significant difference was observed only at the 12.5:1 ratio ( p = 0.012), whereas at week 12, significant differences were observed at the 50:1 and 25:1 ratios ( p = 0.014 and p = 0.040, respectively). No significant between-group differences were observed for the other E:T ratios at each time point. Cytokine levels, white blood cell (WBC) counts, fatigue severity scores (FSS), and upper respiratory tract infections showed no significant differences between the two groups. These findings suggest that LF supplementation enhances NK cell activity and may contribute to immune-related responses in adults while maintaining a favorable safety profile. However, the absence of significant differences in clinical and inflammatory outcomes indicates that the clinical implications of increased NK cell activity should be interpreted with caution.
Zitieren
APA
Park, J., Bae, S., Jang, M., Kim, M. H., Park, H., & Shin, M. (2026). Lactoferrin supplementation enhances natural killer cell activity in adults: findings from a 12-week randomized, double-blind, placebo-controlled trial. Journal of Functional Foods, 146, 107537. https://doi.org/10.1016/j.jff.2026.107537
Vancouver
Park J, Bae S, Jang M, Kim MH, Park H, Shin M. Lactoferrin supplementation enhances natural killer cell activity in adults: findings from a 12-week randomized, double-blind, placebo-controlled trial. Journal of Functional Foods. 2026;146:107537. doi:10.1016/j.jff.2026.107537
BibTeX
@article{Park2026,
author = {Park, Jong-Hwan and Bae, Seongryu and Jang, Minwoo and Kim, Manh Heun and Park, Hyuntae and Shin, Myung-Jun},
title = {Lactoferrin supplementation enhances natural killer cell activity in adults: findings from a 12-week randomized, double-blind, placebo-controlled trial},
journal = {Journal of Functional Foods},
year = {2026},
volume = {146},
pages = {107537},
doi = {10.1016/j.jff.2026.107537}
}
EUVIMED